{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T06:27:14Z","timestamp":1793600834885,"version":"4.5.0"},"reference-count":108,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100013179","name":"Research and Innovative Technology Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013179","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jaci.2026.05.005","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T06:52:01Z","timestamp":1779864721000},"page":"598-609.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Guidance on JAK inhibitor treatment for inborn errors of JAK-STAT signaling, 2026: International consensus statement on behalf of the European Society for Immunodeficiencies\/European Society for Blood and Marrow Transplantation\u2013Inborn Errors Working Party and ERN-RITA"],"prefix":"10.1016","volume":"158","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9853-7903","authenticated-orcid":false,"given":"Peter","family":"Olbrich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngela","family":"Dey\u00e0-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concepci\u00f3n","family":"Campos-Asensio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Neth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Hadjadj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa R.","family":"Forbes Satter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer W.","family":"Leiding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy R.","family":"Torgerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrzad","family":"Bakhtiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safa","family":"Baris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Badolato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark\u00e9ta","family":"Bloomfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie Pauline","family":"Buddingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauri M.","family":"Burroughs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobhan","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan A.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Crickx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Ehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Farmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra F.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Ignacio","family":"Gonz\u00e1lez-Granado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hagin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif Gunnar","family":"Hanitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Hanzlikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Hauck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Ivorra-Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"K\u00f6rholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjan C.","family":"Lankester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy Ronan","family":"Leahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Meyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Milner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohreh","family":"Nademi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Pachlopnik-Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Pergent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Pr\u00e9vot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Rivi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Persio","family":"Roxo-Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina","family":"Sch\u00fctz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary A.","family":"Slatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Soler-Palacin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Warnatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"V\u00edtovcov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian J.","family":"Vaastert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Neven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Speckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2026.05.005_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.671755","article-title":"Primary immune regulatory disorders with an autoimmune lymphoproliferative syndrome\u2013like phenotype: immunologic evaluation, early diagnosis and management","volume":"12","author":"L\u00f3pez-Nevado","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib2","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/ACI.0000000000001039","article-title":"STAT1 and STAT3 gain of function: clinically heterogenous immune regulatory disorders","volume":"24","author":"Olbrich","year":"2024","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jaci.2024.09.020","article-title":"JAK-STAT signaling pathway, immunodeficiency, inflammation, immune dysregulation, and inborn errors of immunity","volume":"155","author":"Samra","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib4","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood-2015-11-679902","article-title":"Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype","volume":"127","author":"Toubiana","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2026.05.005_bib5","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jaci.2022.09.002","article-title":"Monogenic early-onset lymphoproliferation and autoimmunity: natural history of STAT3 gain-of-function syndrome","volume":"151","author":"Leiding","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib6","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1016\/S2665-9913(24)00348-5","article-title":"Clinical manifestations, disease penetrance, and treatment in individuals with SOCS1 insufficiency: a registry-based and population-based study","volume":"7","author":"Hadjadj","year":"2025","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.jaci.2026.05.005_bib7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jaci.2023.10.018","article-title":"JAK inhibitor treatment for inborn errors of JAK\/STAT signaling: an ESID\/EBMT-IEWP retrospective study","volume":"153","author":"Fischer","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib8","doi-asserted-by":"crossref","DOI":"10.70962\/jhi.20250002","article-title":"The 2024 update of IUIS phenotypic classification of human inborn errors of immunity","volume":"1","author":"Bousfiha","year":"2025","journal-title":"J Hum Immun"},{"key":"10.1016\/j.jaci.2026.05.005_bib9","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/annrheumdis-2021-221814","article-title":"The 2021 European Alliance of Associations for Rheumatology\/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE\/PRAAS, SAVI and AGS","volume":"81","author":"Cetin Gedik","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2026.05.005_bib10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/imr.13312","article-title":"JAK\/STAT defects and immune dysregulation, and guiding therapeutic choices","volume":"322","author":"Chaimowitz","year":"2024","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2026.05.005_bib11","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s10875-022-01257-x","article-title":"Impact of JAK inhibitors in pediatric patients with STAT1 gain of function (GOF) mutations\u201410 children and review of the literature","volume":"42","author":"Dey\u00e0-Mart\u00ednez","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib12","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.jaci.2018.07.020","article-title":"Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations","volume":"142","author":"Forbes","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib13","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41584-024-01153-1","article-title":"JAK inhibitor selectivity: new opportunities, better drugs?","volume":"20","author":"Virtanen","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jaci.2026.05.005_bib14","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1126\/science.adq1717","article-title":"JAKing up immunity","volume":"384","author":"Gadina","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.jaci.2026.05.005_bib15","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jaci.2021.08.004","article-title":"JAK-STAT signaling in human disease: from genetic syndromes to clinical inhibition","volume":"148","author":"Luo","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.717388","article-title":"Emerging place of JAK inhibitors in the treatment of inborn errors of immunity","volume":"12","author":"Hadjadj","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib17","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1046\/j.1365-2648.2000.t01-1-01567.x","article-title":"Research guidelines for the Delphi survey technique","volume":"32","author":"Hasson","year":"2000","journal-title":"J Adv Nurs"},{"key":"10.1016\/j.jaci.2026.05.005_bib18","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jaci.2026.05.005_bib19","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/jrsm.1563","article-title":"Citationchaser: a tool for transparent and efficient forward and backward citation chasing in systematic searching","volume":"13","author":"Haddaway","year":"2022","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.jaci.2026.05.005_bib20","article-title":"Efficacy and safety evaluation of JAK inhibitors in patients with immune dysregulation due to JAK-STAT pathway alterations under the umbrella of ESID, ERN-RITA and IPOPI","author":"Olbrich","year":"2025","journal-title":"International Prospective Register of Systematic Reviews (PROSPERO) CRD42023378843"},{"key":"10.1016\/j.jaci.2026.05.005_bib23","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.150849","article-title":"Human JAK1 gain of function causes dysregulated myelopoeisis and severe allergic inflammation","volume":"7","author":"Biggs","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaci.2026.05.005_bib24","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jaci.2024.11.032","article-title":"Ruxolitinib treatment ameliorates clinical, immunologic, and transcriptomic aberrations in patients with STAT3 gain-of-function disease","volume":"155","author":"Bayram Catak","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib25","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.jaip.2020.11.050","article-title":"JAK inhibition in early-onset somatic, nonclonal STAT5B gain-of-function disease","volume":"9","author":"Eisenberg","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2026.05.005_bib26","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jaci.2023.06.004","article-title":"Successful treatment of JAK1-associated inflammatory disease","volume":"152","author":"Fayand","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib27","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMoa2202318","article-title":"Variant STAT4 and response to ruxolitinib in an autoinflammatory syndrome","volume":"388","author":"Baghdassarian","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2026.05.005_bib28","article-title":"Case report: JAK inhibitor treatment of immune dysregulation symptoms in a patient with PTPN2 deficiency","volume":"15","author":"Roppelt","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib29","article-title":"SOCS1 deficiency\u2014crossroads of autoimmunity and autoinflammation\u2014two case reports","volume":"12","author":"Trojovsky","year":"2024","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaci.2026.05.005_bib30","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1007\/s10875-022-01346-x","article-title":"SOCS1 haploinsufficiency presenting as severe enthesitis, bone marrow hypocellularity, and refractory thrombocytopenia in a pediatric patient with subsequent response to JAK inhibition","volume":"42","author":"Michniacki","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib32","series-title":"EMA. Jakavi (ruxolitinib): EPAR\u2014product information","year":"2025"},{"key":"10.1016\/j.jaci.2026.05.005_bib33","series-title":"EMA. Rinvoq (upadacitinib): EPAR\u2014product information","year":"2023"},{"key":"10.1016\/j.jaci.2026.05.005_bib34","series-title":"EMA. Xeljanz (tofacitinib): EPAR\u2014product information","year":"2025"},{"key":"10.1016\/j.jaci.2026.05.005_bib35","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaad.2024.10.108","article-title":"Current evidence on safety of Janus kinase inhibitors in pregnancy and lactation","volume":"92","author":"Gordon","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2026.05.005_bib36","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70429","article-title":"Janus kinase inhibitors during pregnancy and adverse drug reactions: a pharmacovigilance disproportionality analysis in VigiBase","volume":"18","author":"Abolhassani","year":"2025","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jaci.2026.05.005_bib37","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1136\/ard-2023-224049","article-title":"JAK inhibitors and the risk of malignancy: a meta-analysis across disease indications","volume":"82","author":"Russell","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2026.05.005_bib38","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/cid\/civ1220","article-title":"Progressive multifocal leukoencephalopathy in primary immune deficiencies: STAT1 gain of function and review of the literature","volume":"62","author":"Zerbe","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2026.05.005_bib39","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofx202","article-title":"Risks of ruxolitinib in STAT1 gain-of-function-associated severe fungal disease","volume":"4","author":"Zimmerman","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jaci.2026.05.005_bib40","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ajh.24976","article-title":"Ruxolitinib-associated infections: a systematic review and meta-analysis","volume":"93","author":"Lussana","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaci.2026.05.005_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2025.09.021","article-title":"Elevated risk of active tuberculosis with interleukin (IL)-17, IL-23, IL-12\/23, Janus kinase inhibitors, cyclosporine, and tumor necrosis factor-\u03b1 inhibitors compared with the general population: a population-based analysis using TriNetX","author":"Woodie","year":"2025","journal-title":"J Am Acad Dermatol"},{"issue":"suppl","key":"10.1016\/j.jaci.2026.05.005_bib42","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/j.jinf.2016.04.023","article-title":"Treatment options for chronic mucocutaneous candidiasis","volume":"72","author":"van de Veerdonk","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.jaci.2026.05.005_bib43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10875-024-01684-y","article-title":"Patients with STAT1 gain-of-function mutations display increased apoptosis which is reversed by the JAK inhibitor ruxolitinib","volume":"44","author":"Dotta","year":"2024","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib44","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s10875-022-01351-0","article-title":"Three adult cases of STAT1 gain-of-function with chronic mucocutaneous candidiasis treated with JAK inhibitors","volume":"43","author":"Borgstr\u00f6m","year":"2023","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib45","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5114\/ceji.2022.114884","article-title":"Chronic mucocutaneous candidiasis, pancytopenia, and systemic mycosis in a patient with STAT1 gene mutation ineffectively treated with ruxolitinib","volume":"47","author":"Bazan-Socha","year":"2022","journal-title":"Cent Eur J Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib46","doi-asserted-by":"crossref","first-page":"e899","DOI":"10.1111\/jdv.18326","article-title":"Utility of ruxolitinib in a patient with chronic mucocutaneous candidiasis caused by STAT1 gain-of-function mutation","volume":"36","author":"Olivier","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2026.05.005_bib47","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s10875-020-00943-y","article-title":"Stepwise reversal of immune dysregulation due to STAT1 gain-of-function mutation following ruxolitinib bridge therapy and transplantation","volume":"41","author":"Kayaoglu","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib48","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s12185-020-02860-7","article-title":"Ruxolitinib treatment of a patient with steroid-dependent severe autoimmunity due to STAT1 gain-of-function mutation","volume":"112","author":"Moriya","year":"2020","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jaci.2026.05.005_bib49","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s10875-018-0519-6","article-title":"Utility of ruxolitinib in a child with chronic mucocutaneous candidiasis caused by a novel STAT1 gain-of-function mutation","volume":"38","author":"Bloomfield","year":"2018","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib50","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jaci.2018.02.045","article-title":"Baricitinib treatment in a patient with a gain-of-function mutation in signal transducer and activator of transcription 1 (STAT1)","volume":"142","author":"Meesilpavikkai","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib51","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3389\/fimmu.2019.01433","article-title":"STAT1 gain-of-function mutations cause high total STAT1 levels with normal dephosphorylation","volume":"10","author":"Zimmerman","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1095595","article-title":"Case report: myocarditis in congenital STAT1 gain-of function","volume":"14","author":"Staels","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib53","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.medj.2021.12.003","article-title":"JAK inhibition in a patient with a STAT1 gain-of-function variant reveals STAT1 dysregulation as a common feature of aplastic anemia","volume":"3","author":"Rosenberg","year":"2022","journal-title":"Med"},{"key":"10.1016\/j.jaci.2026.05.005_bib54","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/1093526620985950","article-title":"Bronchiectasis and bronchiolectasis with severe herniating pattern associated with STAT1 gain-of-function mutation: detailed clinicopathological findings","volume":"24","author":"Takeda","year":"2021","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.jaci.2026.05.005_bib55","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1097\/MPG.0000000000002854","article-title":"Ruxolitinib response in an infant with very-early-onset inflammatory bowel disease and gain-of-function STAT1 mutation","volume":"71","author":"Acker","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaci.2026.05.005_bib56","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s10875-024-01776-9","article-title":"Immunophenotyping and therapeutic insights from chronic mucocutaneous candidiasis cases with STAT1 gain-of-function mutations","volume":"44","author":"Lei","year":"2024","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.anai.2017.08.200","article-title":"STAT1 gain of function mutation treated with ruxolitinib","volume":"119","author":"Schussler","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib58","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.molimm.2019.07.008","article-title":"Identification of a distinct subset of disease-associated gain-of-function missense mutations in the STAT1 coiled-coil domain as system mutants","volume":"114","author":"Petersen","year":"2019","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib59","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jaci.2014.12.1867","article-title":"Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation","volume":"135","author":"Higgins","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib60","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.3390\/biomedicines11051299","article-title":"Inborn errors of immunity in children with autoimmune and allergic complaints: a single center experience from diagnosis to treatment","volume":"11","author":"Boz","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jaci.2026.05.005_bib61","doi-asserted-by":"crossref","first-page":"334","DOI":"10.47429\/lmo.2020.10.4.334","article-title":"The usefulness of flow cytometry for measuring phosphorylated signal transducer and activator of transcription 1 to diagnose and manage chronic mucocutaneous candidiasis: a case report","volume":"10","author":"Yoon","year":"2020","journal-title":"Lab Med Online"},{"key":"10.1016\/j.jaci.2026.05.005_bib62","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/imj.78_13578","article-title":"Ruxolitinib use in a child with chronic mucocutaneous candidiasis and autosomal dominant signal transducer and activator of transcription 1 gain of function (STAT1 GOF) mutation","volume":"47","author":"Chan","year":"2017","journal-title":"Intern Med J"},{"key":"10.1016\/j.jaci.2026.05.005_bib63","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s10067-022-06415-5","article-title":"Cardiovascular risks associated with Janus kinase inhibitors: peering outside the black box","volume":"42","author":"Misra","year":"2023","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaci.2026.05.005_bib64","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2109927","article-title":"Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis","volume":"386","author":"Ytterberg","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2026.05.005_bib65","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1093\/rheumatology\/kead211","article-title":"Venous and arterial thromboembolic risk of Janus kinase inhibitors: a systematic review with meta-analysis","volume":"62","author":"Campanaro","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaci.2026.05.005_bib66","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s10875-022-01232-6","article-title":"STAT3 GOF with polycythemia: a twist to the tale-first case report from India","volume":"42","author":"Gowri","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.928213","article-title":"Case report: a STAT1 gain-of-function mutation causes a syndrome of combined immunodeficiency, autoimmunity and pure red cell aplasia","volume":"13","author":"Xie","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib68","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jaci.2023.01.023","article-title":"Severe allergic dysregulation due to a gain of function mutation in the transcription factor STAT6","volume":"152","author":"Baris","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"suppl 1","key":"10.1016\/j.jaci.2026.05.005_bib69","article-title":"Gaining more insight into STAT3 gain-of-function disease: a case presentation","volume":"131","author":"Cherk","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib70","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jaci.2019.11.042","article-title":"Erythropoiesis defect observed in STAT3 GOF patients with severe anemia","volume":"145","author":"Mauracher","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib71","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1053\/j.gastro.2018.11.065","article-title":"Efficacy of ruxolitinib therapy in a patient with severe enterocolitis associated with a STAT3 gain-of-function mutation","volume":"156","author":"Parlato","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2026.05.005_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1400348","article-title":"JAK inhibitors to treat STAT3 gain-of-function: a single-center report and literature review","volume":"15","author":"Atschekzei","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib73","doi-asserted-by":"crossref","DOI":"10.1093\/immadv\/ltad027","article-title":"Janus kinase inhibitors ameliorate clinical symptoms in patients with STAT3 gain-of-function","volume":"3","author":"Kaneko","year":"2023","journal-title":"Immunother Adv"},{"key":"10.1016\/j.jaci.2026.05.005_bib74","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/13816810.2019.1592202","article-title":"Papilledema from gain-of-function mutations in the STAT3 gene","volume":"40","author":"Suh","year":"2019","journal-title":"Ophthalmic Genet"},{"key":"10.1016\/j.jaci.2026.05.005_bib75","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221755","article-title":"Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease","volume":"220","author":"Sharma","year":"2023","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2026.05.005_bib76","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1056\/NEJMc2311867","article-title":"JAK inhibition in STAT1 gain-of-function\u2013mediated treatment-resistant autoimmune hepatitis","volume":"390","author":"Had\u017ei\u0107","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2026.05.005_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109174","article-title":"Aberrant tolerogenic functions and proinflammatory skew of dendritic cells in STAT1 gain-of-function patients may contribute to autoimmunity and fungal susceptibility","volume":"246","author":"Parackova","year":"2023","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib78","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10875-015-0214-9","article-title":"The extended clinical phenotype of 26 patients with chronic mucocutaneous candidiasis due to gain-of-function mutations in STAT1","volume":"36","author":"Depner","year":"2016","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib79","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3389\/fimmu.2020.01065","article-title":"Primary immunodeficiencies with defects in innate immunity: focus on orofacial manifestations","volume":"11","author":"Jung","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib80","article-title":"Dosing ruxolitinib for the treatment of immunodysregulation in STAT1-GOF","volume":"39","author":"Jadoul","year":"2019","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib81","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.immuni.2020.07.006","article-title":"Complex autoinflammatory syndrome unveils fundamental principles of JAK1 kinase transcriptional and biochemical function","volume":"53","author":"Gruber","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.05.005_bib82","doi-asserted-by":"crossref","DOI":"10.1097\/WNO.0000000000002272","article-title":"Chronic atypical optic disc edema in a boy with STAT3 gain-of-function syndrome","volume":"45","author":"Ahmad","year":"2025","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.jaci.2026.05.005_bib83","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s10875-020-00914-3","article-title":"Life-saving, dose-adjusted, targeted therapy in a patient with a STAT3 gain-of-function mutation","volume":"41","author":"Sarfati","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib84","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s10875-024-01687-9","article-title":"Ruxolitinib improves immune-dysregulation features but not epigenetic abnormality in a patient with STAT1 GOF","volume":"44","author":"Koh","year":"2024","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.anai.2020.08.268","article-title":"Progressive gait instability and intracranial lesions of unknown etiology in STAT1 GOF mutation","volume":"125","author":"Biswas","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib86","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s10875-023-01454-2","article-title":"STAT1 gain-of-function and hidradenitis suppurativa successfully managed with baricitinib","volume":"43","author":"Olbrich","year":"2023","journal-title":"J Clin Immunol"},{"issue":"suppl 1","key":"10.1016\/j.jaci.2026.05.005_bib87","article-title":"Successful allogeneic haematopoietic stem cell transplantation in a child with severe immunodeficiency 31-C (OMIM #614162) due to STAT1-GOF mutation. In: UKPIN 2015 Meeting Abstracts, December 2015: Oral Presentations","volume":"182","author":"Abinun","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib88","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1016\/j.cell.2022.09.023","article-title":"The JAK-STAT pathway at 30: much learned, much more to do","volume":"185","author":"Philips","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2026.05.005_bib89","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41584-022-00767-7","article-title":"Oral surveillance and JAK inhibitor safety: the theory of relativity","volume":"18","author":"Winthrop","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jaci.2026.05.005_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1494901","article-title":"JAK inhibitors: an evidence-based choice of the most appropriate molecule","volume":"15","author":"Antonioli","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaci.2026.05.005_bib91","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1093\/rheumatology\/keaa117","article-title":"Pulmonary adverse events of small molecule JAK inhibitors in autoimmune disease: systematic review and meta-analysis","volume":"59","author":"Khoo","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaci.2026.05.005_bib92","doi-asserted-by":"crossref","first-page":"7140","DOI":"10.1038\/s41598-022-10777-w","article-title":"Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database","volume":"12","author":"Hoisnard","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2026.05.005_bib93","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s10875-024-01720-x","article-title":"Qualitative immunoglobulin deficiency causes bacterial infections in patients with STAT1 gain-of-function mutations","volume":"44","author":"Chen","year":"2024","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib94","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/ijd.70033","article-title":"Vaccination recommendations in patients with atopic dermatitis treated with JAK inhibitors","volume":"65","author":"Ara-Mart\u00edn","year":"2026","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaci.2026.05.005_bib95","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ard.2025.01.032","article-title":"Expert consensus statement on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: 2024 update","volume":"84","author":"Nash","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2026.05.005_bib96","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/imr.13300","article-title":"Human STAT1 gain of function with chronic mucocutaneous candidiasis: a comprehensive review for strengthening the connection between bedside observations and laboratory research","volume":"322","author":"Asano","year":"2024","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2026.05.005_bib97","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1084\/jem.20110958","article-title":"Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis","volume":"208","author":"Liu","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2026.05.005_bib98","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1717692","article-title":"The T385M STAT1 gain-of-function mutation confers the most severe disease outcomes","volume":"16","author":"Torrance","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib99","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1016\/S1473-3099(24)00749-7","article-title":"Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM","volume":"25","author":"Cornely","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jaci.2026.05.005_bib100","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3390\/jof9020149","article-title":"Inborn errors of immunity causing pediatric susceptibility to fungal diseases","volume":"9","author":"Olbrich","year":"2023","journal-title":"J Fungi Basel Switz"},{"key":"10.1016\/j.jaci.2026.05.005_bib101","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1007\/s10875-023-01519-2","article-title":"Successful rezafungin treatment of an azole-resistant chronic mucocutaneous candidiasis in a STAT-1 gain-of-function patient","volume":"43","author":"Melenotte","year":"2023","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib102","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12941-025-00830-7","article-title":"Current infectious disease management challenges in inborn errors of immunity","volume":"24","author":"Zheng","year":"2025","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.jaci.2026.05.005_bib103","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jaci.2019.01.051","article-title":"Double-blind, placebo-controlled, randomized trial on low-dose azithromycin prophylaxis in patients with primary antibody deficiencies","volume":"144","author":"Milito","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib104","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.jaci.2016.07.015","article-title":"Efficacy of the Janus kinase 1\/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children","volume":"138","author":"Fr\u00e9mond","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib105","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/blood.2023022565","article-title":"Ruxolitinib for pediatric patients with treatment-na\u00efve and steroid-refractory acute graft-versus-host disease: the REACH4 study","volume":"144","author":"Locatelli","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2026.05.005_bib106","first-page":"1485","article-title":"Pharmacology of inhibitors of Janus kinases\u2014part 1: pharmacokinetics","volume":"20","author":"Eichner","year":"2022","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaci.2026.05.005_bib107","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/rheumatology\/kead448","article-title":"Differential properties of Janus kinase inhibitors in the treatment of immune-mediated inflammatory diseases","volume":"63","author":"Taylor","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaci.2026.05.005_bib108","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41408-020-00392-1","article-title":"Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis","volume":"11","author":"Palandri","year":"2021","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jaci.2026.05.005_bib109","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaci.2017.03.049","article-title":"Hematopoietic stem cell transplantation in patients with gain-of-function signal transducer and activator of transcription 1 mutations","volume":"141","author":"Leiding","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.005_bib110","doi-asserted-by":"crossref","DOI":"10.70962\/jhi.20250027","article-title":"Improved outcome of HSCT in STAT1 gain-of-function disease following JAK inhibition bridging","volume":"1","author":"Buddingh","year":"2025","journal-title":"J Hum Immun"},{"key":"10.1016\/j.jaci.2026.05.005_bib111","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.3324\/haematol.2019.216101","article-title":"Role of interferon-\u03b3 in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation","volume":"104","author":"Merli","year":"2019","journal-title":"Haematologica"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009167492600343X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009167492600343X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:35:46Z","timestamp":1793597746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009167492600343X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":108,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S009167492600343X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2026.05.005","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guidance on JAK inhibitor treatment for inborn errors of JAK-STAT signaling, 2026: International consensus statement on behalf of the European Society for Immunodeficiencies\/European Society for Blood and Marrow Transplantation\u2013Inborn Errors Working Party and ERN-RITA","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2026.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}